Rhonda Farnum's Net Worth
$3.75 Million
Who is Rhonda Farnum?
Rhonda Farnum has an estimated net worth of $3.75 Million. This is based on reported shares in Theravance Biopharma, Inc..
SEC CIK
Rhonda Farnum's CIK is 0001898490
Past Insider Trading and Trends
2021 was Rhonda Farnum's most active year for acquiring shares with 1 total transactions. Rhonda Farnum's most active month to acquire stocks was the month of February. 2023 was Rhonda Farnum's most active year for disposing of shares, totalling 8 transactions. Rhonda Farnum's most active month to dispose stocks was the month of January. 2023 saw Rhonda Farnum paying a total of $0.00 for 75,000 shares, this is the most they've acquired in one year. In 2022 Rhonda Farnum cashed out on 51,142 shares for a total of $516,171.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.505
SVP, COMM & MEDICAL AFFAIRS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.18% | -4.00K |
$9.00 | -$36,000.00 | 335.96K |
Scheduled
|
Jul 10
| ||
Form 4
| -2.65% | -9.27K |
$9.10 | -$84,338.80 | 339.96K |
May 20
| |||
Form 4
| +12.03% | 37.5K |
—
|
—
| 349.23K |
Apr 2
| |||
Form 4
| -5.88% | -19.47K |
$8.91 | -$173,435.82 | 311.73K |
Scheduled
|
Feb 20 - Feb 22
| ||
Form 4
| -2.75% | -9.36K |
$10.36 | -$96,952.96 | 331.21K |
Scheduled
|
Nov 20 - Nov 21
| ||
Form 4
| -0.53% | -1.81K |
$9.47 | -$17,112.29 | 340.57K |
Aug 22
| |||
Form 4
| -2.96% | -10.46K |
$9.70 | -$101,462.00 | 342.37K |
Aug 20
| |||
Form 4
| -0.50% | -1.79K |
$11.13 | -$19,922.70 | 352.83K |
Jun 8
| |||
Form 4
| -1.55% | -5.57K |
$11.21 | -$62,406.07 | 354.62K |
May 20
| |||
Form 4
| -1.10% | -4.00K |
$10.20 | -$40,800.00 | 360.19K |
Mar 9
| |||
Form 4
| +25.93% | 75K |
—
|
—
| 364.19K |
Mar 1
| |||
Form 4
| -2.40% | -7.12K |
$10.44 | -$74,322.36 | 289.19K |
Feb 20
| |||
Form 4
| -7.28% | -23.27K |
$10.85 | -$252,457.80 | 296.31K |
Nov 20
| |||
Form 4
| -3.16% | -10.41K |
$9.34 | -$97,257.42 | 319.58K |
Aug 19
| |||
Form 4
| -0.98% | -3.28K |
$8.80 | -$28,881.33 | 329.99K |
Scheduled
|
May 20 - May 23
| ||
Form 4
| -0.70% | -2.36K |
$10.16 | -$23,946.62 | 333.27K |
Scheduled
|
Feb 28
| ||
Form 4
| -3.40% | -11.82K |
$9.61 | -$113,628.64 | 335.63K |
Feb 18
| |||
Form 4
| +8.60% | 27.5K |
—
|
—
| 347.45K |
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||